Network for excellence in neuroscience clinical trials NeuroNEXT

JAMA Neurology

Volumn 70, Issue 10, 2013, Pages 1227-1228

  Love, Marissa Natelson ^a   Fathallah Shaykh, Hassah ^a,b,c,d,e,f  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d 803 Shelby Interdisciplinary Biomedical Research Building   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ALZHEIMER DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); HUMAN; INFORMATION PROCESSING; MEDICAL LITERATURE; MEDICAL RESEARCH; NEUROLOGIC DISEASE; NEUROSCIENCE; NOTE; PATENT; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PUBLISHING; STUDY DESIGN; UNITED STATES;

EID: 84885803564     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.3663     Document Type: Note

References (4)

1. NeuroNEXT website. http://www.neuronext.org/Accessed May 12, 2013.
2. NeuroNEXT: Network for Excellence in Neuroscience Clinical Trials. National Institute of Neurological Disorders and Stroke website. http://www.ninds.nih.gov/news-and-events/proceedings/20101217-NEXT.htm. Accessed May 12, 2013.
3. Shaw G. NeuroNEXT: new neuroscience network aims to speed up phase 2 trials. Neurol Today. 2011;11(24):24-27. doi:10.1097/01.NT.0000410295.08607. http://journals.lww.com/neurotodayonline/Fulltext/2011/12150/ NeuroNEXT-New-Neuroscience-Network-Aims-to-Speed.7.aspx. Accessed May 12, 2013.
4. Pan JJ, Nahm M, Wakim P, et al. A centralized informatics infrastructure for the National Institute on Drug Abuse Clinical Trials Network. Clin Trials. 2009;6(1):67-75.